Inogen (INGN) Total Non-Current Liabilities (2013 - 2026)

Inogen's (INGN) quarterly Total Non-Current Liabilities came in at $84.6 million in Q1 2026, down 10.19% year-on-year from $94.2 million in Q1 2025, and down 4.05% on a QoQ basis from $88.2 million in Q4 2025.

Inogen (INGN) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Inogen (INGN) has 14 years of Total Non-Current Liabilities data on file, last reported at $84.6 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 10.19% year-over-year to $84.6 million in Q1 2026; TTM through Mar 2026 was $84.6 million, a 10.19% decrease from a year earlier, with the FY2025 full-year figure at $88.2 million, down 19.32% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $84.6 million, down from $88.2 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for INGN reached as high as $113.1 million in Q1 2024 and fell as low as $84.6 million in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $100.7 million across 5 years, with a median of $104.6 million in 2024.
  • Across the five-year window, Total Non-Current Liabilities gained 26.64% in 2024 and dropped 19.32% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $95.5 million in 2022, then rose by 12.58% to $107.5 million in 2023, then gained by 1.67% to $109.3 million in 2024, then fell by 19.32% to $88.2 million in 2025, then slipped by 4.05% to $84.6 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $84.6 million in Q1 2026, $88.2 million in Q4 2025, and $92.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Inogen 172.68 Mn 62.51 Mn 37.86 Mn 84.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.63 Mn
Dec 31, 2025 88.20 Mn
Sep 30, 2025 92.02 Mn
Jun 30, 2025 95.56 Mn
Mar 31, 2025 94.23 Mn
Dec 31, 2024 109.33 Mn
Sep 30, 2024 104.59 Mn
Jun 30, 2024 110.14 Mn
Mar 31, 2024 113.13 Mn
Dec 31, 2023 107.53 Mn
Sep 30, 2023 109.89 Mn
Jun 30, 2023 86.98 Mn
Mar 31, 2023 92.36 Mn
Dec 31, 2022 95.51 Mn
Sep 30, 2022 111.11 Mn
Jun 30, 2022 106.39 Mn
Mar 31, 2022 109.76 Mn
Dec 31, 2021 112.04 Mn
Sep 30, 2021 113.33 Mn
Jun 30, 2021 118.13 Mn